Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac extracellular matrix is a dynamic, 3-dimensional network of macromolecules (e.g., collagens, laminins, fibronectin, proteoglycans) that provides both structural and regulatory support to cardiac cells. This system governs tissue architecture, cell adhesion, migration, and survival, and actively participates in tissue regeneration, fibrosis, and pathological remodeling during cardiovascular disease. Cardiac cells—primarily cardiomyocytes, fibroblasts, endothelial cells, and smooth muscle cells—produce and respond to signals from the extracellular matrix through receptors such as integrins, resulting in feedback loops that shape heart health and disease processes[1][2][3]. The ECM and its interactions with cardiac cells are crucial in development, homeostasis, and adaptation to injury, but are not a singular molecular target.
Inhibition of ECM remodeling (e.g., reduction of fibrosis); Modulation of cell-matrix interactions (e.g., via integrins, MMPs)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac extracellular matrix (with associated cardiac cells) (ECM (for extracellular matrix); cardiac cells are not abbreviated as a target).